These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 330978)

  • 1. Management of metastatic breast cancer.
    Haskell CM
    Med Clin North Am; 1977 Sep; 61(5):967-78. PubMed ID: 330978
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic treatment of breast cancer: past, present and future.
    Carbone PP
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):759-67. PubMed ID: 977407
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemo immunotherapy of advanced breast cancer with BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Buzdar A; Burgess MA; Richman SP; Tashima CK; Schwarz M; Hersh EM
    Recent Results Cancer Res; 1977; (62):143-50. PubMed ID: 601328
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic therapy for metastatic breast cancer.
    Haskell CM; Sparks FC; Graze PR; Korenman SG
    Ann Intern Med; 1977 Jan; 86(1):68-80. PubMed ID: 835932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemo- and hormonal therapy in advanced breast cancer.
    Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P
    Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T; Rosner D; Diaz R; Dao T; Sponzo R; Cunningham T; Horton J; Simon R
    Cancer; 1978 Jun; 41(6):2073-7. PubMed ID: 657080
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of nonspecific immunotherapy in the treatment of breast cancer.
    Israel L
    Recent Results Cancer Res; 1976; (57):189-95. PubMed ID: 1013508
    [No Abstract]   [Full Text] [Related]  

  • 8. Are surgical adjuvant trials altering the course of breast cancer?
    Bonadonna G; Valagussa P; Rossi A; Zucali R; Tancini G; Bajetta E; Brambilla C; De Lena M; Di Fronzo G; Banfi A; Rilke F; Veronesi U
    Semin Oncol; 1978 Dec; 5(4):450-64. PubMed ID: 366757
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of lung cancer. II. Review of clinical trials in small cell carcinoma.
    Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
    Cancer Treat Rev; 1979 Jun; 6(2):125-30. PubMed ID: 226262
    [No Abstract]   [Full Text] [Related]  

  • 10. A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas.
    Creagan ET; Edmonson JH; Hahn RG; Ahmann DL; Bisel HF; Eagan RT
    Med Pediatr Oncol; 1978; 4(1):85-6. PubMed ID: 625266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
    Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
    Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine.
    Hortobagyi GN; Yap HY; Wiseman CL; Blumenschein GR; Buzdar AU; Legha SS; Gutterman JU; Hersh EM; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):157-9. PubMed ID: 6991103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
    Yap HY; Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Krutchik AN; Benjamin RS; Gutterman JU; Bodey GP
    J Surg Oncol; 1979 Dec; 12(4):333-41. PubMed ID: 392197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.
    Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
    Cancer Treat Rev; 1979 Sep; 6(3):177-90. PubMed ID: 394836
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
    Mathe G
    Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenalectomy for palliation of metastatic breast cancer.
    Dao TL
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):473-6. PubMed ID: 80401
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; DeBanne SM; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Cancer; 1980 Dec; 46(12 Suppl):2805-8. PubMed ID: 7004624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of the breast: the past decade (second of two parts).
    Henderson IC; Canellos GP
    N Engl J Med; 1980 Jan; 302(2):78-90. PubMed ID: 7350436
    [No Abstract]   [Full Text] [Related]  

  • 20. Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.
    Buzdar AU; Blumenschein GR; Gutterman JU; Tashima CK; Hortobagyi GN; Smith TL; Campos LT; Wheeler WL; Hersh EM; Freireich EJ; Gehan EA
    JAMA; 1979 Oct; 242(14):1509-13. PubMed ID: 470088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.